The rights offering (the “Offering”) made by The Gabelli Healthcare &
WellnessRx Trust (the “Fund”) (NYSE:GRX) to the Fund’s common
shareholders will expire on Wednesday, July 17, 2013 at 5:00 PM
Eastern time.
SUMMARY OF THE TERMS OF THE OFFERING
-
Each shareholder received one transferable right (the “Right”) for
each common share held on the record date (June 17, 2013).
-
Three Rights plus $9.00 (the “Subscription Price”) is required to
purchase one additional common share (the “Primary Subscription”). The
purchase price is payable in cash.
-
Record date shareholders who fully exercise their Primary Subscription
Rights are eligible for an over-subscription privilege entitling these
shareholders to subscribe, subject to certain limitations and a
pro-rata allotment, for any additional common shares not purchased
pursuant to the Primary Subscription. Rights acquired in the
secondary market may not participate in the over-subscription
privilege.
-
Rights may be traded on the NYSE under the symbol “GRX RT”.
Holders of Rights who wish to subscribe for additional common shares
should contact their broker for instructions with respect to exercising
Rights. Holders of Rights who are unable or do not wish to exercise any
or all of their Rights may instruct their broker to sell any unexercised
Rights.
The Offering is made pursuant to the Fund’s effective shelf registration
statement on file with the Securities and Exchange Commission (the
“SEC”). As previously announced, investments of the proceeds raised will
be made in accordance with the Fund’s investment objectives and policies
as appropriate new investment opportunities are identified.
For questions and further information contact the Closed-End Fund Team
at 800-GABELLI (800-422-3554) or (914) 921-5070. Morrow & Co., LLC is
serving as the Information Agent for this offering and can be reached at
(800) 969-2372, Banks and Brokers please call (203) 658-9400. This
document is not an offering, which can only be made by a final
prospectus. Investors should carefully consider the Fund’s
investment objectives, risks, charges and expenses before investing.
The base prospectus and statement of additional information
contain this and additional information about the Fund, and the
prospectus supplement contains this and additional information about the
Offering, and should be read carefully before investing. The SEC
has not approved or disapproved these securities or passed upon the
adequacy of this press release.
The Gabelli Healthcare & WellnessRx Trust is a
diversified, closed-end management investment company with approximately
$157 million in total net assets whose investment objective is long-term
growth of capital. The Fund is managed by Gabelli Funds, LLC, a
subsidiary of GAMCO Investors, Inc. (NYSE:GBL), which is a publicly
traded NYSE listed company.
Copyright Business Wire 2013